Clinical Trial Update: Masitinib Plus Gemcitabine in Pancreatic Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial update for masitinib plus gemcitabine in locally advanced or metastatic pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Masitinib (masitinib)

Snippet

Sponsor: AB Science | Conditions: Locally Advanced or Metastatic Pancreatic Cancer | Phase 3 | Status: COMPLETED